Blueberry Therapeutics: Funding, Investors & Team (Oct 2026)
Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better. Blueberry focuses on the research and development of treatments for inflammatory and infectious diseases. We do this by employing state of the art preclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.
Blueberry Therapeutics has raised $6.1M across 2 funding rounds on record, the most recent an undisclosed round of $1.1M announced in Jun 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Blueberry Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Blueberry Therapeutics Funding Rounds
Blueberry Therapeutics raised $5.0M in a Series B announced in Feb 2021.
4 months later, an undisclosed round of $1.1M was announced in Jun 2021.
Blueberry Therapeutics Founders and Leadership Team
Contact details for the Blueberry Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Blueberry Therapeutics Funding Compared to Other Biotechnology Startups
Blueberry Therapeutics' latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Blueberry Therapeutics in Biotechnology and Alderley Edge
Companies Similar to Blueberry Therapeutics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Blueberry Therapeutics Funding FAQs
What does Blueberry Therapeutics do?
Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better. Blueberry focuses on the research and development of treatments for inflammatory and infectious diseases. We do this by employing state of the art preclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.
How much funding has Blueberry Therapeutics raised?
Blueberry Therapeutics has raised $6.1M across 2 rounds on record. The most recent is an undisclosed round of $1.1M announced in Jun 2021.
When did Blueberry Therapeutics last raise funding?
Blueberry Therapeutics' most recent funding round on record is an undisclosed round of $1.1M, announced in Jun 2021.
Who is the CEO of Blueberry Therapeutics?
John Ridden is listed as CEO at Blueberry Therapeutics.
Where is Blueberry Therapeutics headquartered?
Blueberry Therapeutics is based in Alderley Edge, Cheshire, United Kingdom.
How many employees does Blueberry Therapeutics have?
Blueberry Therapeutics is in the 11-50 employee band.
How does Blueberry Therapeutics' funding compare to other Biotechnology startups?
Blueberry Therapeutics' latest round of $1.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Blueberry Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Blueberry Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.